RT Journal Article
SR Electronic
T1 Safety and efficacy of restarting immune checkpoint inhibitors after clinically significant immune-related adverse events in metastatic renal cell carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e000144
DO 10.1136/jitc-2019-000144
VO 8
IS 1
A1 Abou Alaiwi, Sarah
A1 Xie, Wanling
A1 Nassar, Amin H
A1 Dudani, Shaan
A1 Martini, Dylan
A1 Bakouny, Ziad
A1 Steinharter, John A
A1 Nuzzo, Pier Vitale
A1 Flippot, Ronan
A1 Martinez-Chanza, Nieves
A1 Wei, Xiao
A1 McGregor, Bradley A
A1 Kaymakcalan, Marina D
A1 Heng, Daniel Y C
A1 Bilen, Mehmet A
A1 Choueiri, Toni K
A1 Harshman, Lauren C
YR 2020
UL http://jitc.bmj.com/content/8/1/e000144.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.